The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[20-Methyl-9,10-seco-5,7,10(19)-pregnatriene-3beta,20-diol ID: ALA3275631
PubChem CID: 90679168
Max Phase: Preclinical
Molecular Formula: C22H34O2
Molecular Weight: 330.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H](C(C)(C)O)CC[C@@H]12
Standard InChI: InChI=1S/C22H34O2/c1-15-7-10-18(23)14-17(15)9-8-16-6-5-13-22(4)19(16)11-12-20(22)21(2,3)24/h8-9,18-20,23-24H,1,5-7,10-14H2,2-4H3/b16-8+,17-9-/t18-,19-,20+,22-/m0/s1
Standard InChI Key: JHTHNWHPKZQFFS-RPTOKDGXSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
6.4143 -22.9673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2789 -24.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2789 -25.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4143 -23.7927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9880 -23.7927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7011 -24.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2037 -22.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9880 -25.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7011 -22.5546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7011 -25.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9880 -22.9673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2037 -24.0423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5657 -23.7927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6925 -23.3800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5657 -25.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6417 -22.0044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4143 -22.1419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8525 -24.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8525 -25.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1245 -25.4434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4671 -21.9874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2037 -21.3060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4143 -24.6180 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
4.2727 -23.3768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0494 -21.2842 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 0
4 1 1 0
5 11 1 0
6 4 1 0
7 1 1 0
8 10 1 0
9 1 1 0
10 6 2 0
11 9 1 0
12 4 1 0
13 2 1 0
14 7 1 0
15 3 1 0
7 16 1 1
1 17 1 1
18 13 1 0
19 18 1 0
19 20 1 1
21 16 1 0
16 22 1 0
4 23 1 6
12 14 1 0
6 5 1 0
3 8 2 0
15 19 1 0
2 24 2 0
16 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 330.51Molecular Weight (Monoisotopic): 330.2559AlogP: 4.93#Rotatable Bonds: 2Polar Surface Area: 40.46Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.67CX LogD: 3.67Aromatic Rings: ┄Heavy Atoms: 24QED Weighted: 0.75Np Likeness Score: 2.78
References 1. Johnson RL, Carey SC, Norman AW, Okamura WH.. (1977) Studies on vitamin D (calciferol) and its analogues. 10. Side-chain analogues of 25-hydroxyvitamin D3., 20 (1): [PMID:833826 ] [10.1021/jm00211a002 ]